Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

Completed · Phase 1 · Has a placebo group

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.

Key facts

Study ID

NCT00829816

Run by

Medivation, Inc.

People needed

46

Starts

2008-12-01

Expected to finish

2010-08-01

Last updated by the study team

2015-11-10

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Alzheimer's disease
• On Memantine
• Caregiver who is willing to accompany the patient to all clinic visits

You may not qualify if…

• Unstable medical illnesses or significant hepatic or renal disease
• Other primary psychiatric or neurological disorders

Where it is running

• Study site — Los Alamitos, California, United States
• Study site — National City, California, United States
• Study site — Delray Beach, Florida, United States
• Study site — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.